Le Lézard
Classified in: Health
Subjects: CCA, BFA, PET, FVT

Aratana Therapeutics to Report Third Quarter 2017 Financial Results



LEAWOOD, Kan., Oct. 5, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, November 3, 2017 at 8:30 a.m. ET to discuss financial results from the third quarter ended September 30, 2017.

Aratana Therapeutics logo

Interested participants and investors may access the audio webcast or use the conference call dial-in:

     1 (866) 364-3820 (U.S.) 
     1 (855) 669-9657 (Canada)
     1 (412) 902-4210 (International)

A replay of the third quarter results teleconference will be available the same day of the event by approximately 11 a.m. ET and an audio webcast will be accessible for 90 days in the Aratana Investor Room. For a replay of the call, use the below dial-in and conference ID 10112622:

     1 (877) 344-7529 (U.S.) 
     1 (855) 669-9658 (Canada
     1 (412) 317-0088 (International)

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to dogs and cats in a capital and time efficient manner. The company's pipeline includes therapeutic candidates for the potential treatment of pain, inappetence, viral diseases, allergy, cancer and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com 
(913) 353-1026

For media inquiries:
Rachel Reiff
rreiff@aratana.com 
(913) 353-1050

SOURCE Aratana Therapeutics, Inc.


These press releases may also interest you

at 00:50
VANCOUVER, Oct. 18, 2017 /CNW/ - World Menopause Day 2017 is raising awareness of bleeding in perimenopause, and how different it can be for some women. This is a good thing, according to Shirley Weir, founder of MenopauseChicks.com....

at 00:39
Product photos are available at http://bit.ly/2yw3jrd OTTAWA, Oct. 17, 2017 /CNW/ - Sofina Foods Inc. is recalling Janes brand frozen uncooked breaded chicken products from the marketplace due to possible Salmonella contamination. Consumers should...

at 00:33
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International...

17 oct 2017
MURRIETA, Calif., Oct. 18, 2017 /PRNewswire/ -- Axene Health Partners, LLC (AHP) has published a multi-part report on accountability in the healthcare system. The actuarial, clinical and IT consultants who comprise AHP have experience working with...

17 oct 2017
SACRAMENTO, Calif., Oct. 17, 2017 /CNW/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting...

17 oct 2017
LONDON, Oct. 17, 2017 /PRNewswire/ -- Global Hip Reconstruction Devices Market: Overview Of late, the global market for hip reproduction device has been witnessing a significant rise in its valuation. The technological advancements, continued...




News published on 5 october 2017 at 16:30 and distributed by: